Tag: Lutetium (177Lu) vipivotide tetraxetan

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Lutetium (177Lu) vipivotide tetraxetan

Point Bio Prostate Cancer Therapy Meets Phase 3 Goal, But Results Still Disappoint

Added to Collection on: 2023-12-18 23:15:18

Tags for this article:

Medical physics
Eli Lilly and Company
Research and development in the United States
Radiation therapy
Lutetium (177Lu) vipivotide tetraxetan
Prostate cancer
Clinical trial

Click the tags to see associated articles and topics

View Article Details
Novartis extends radiopharma plans with $1B acquisition of Mariana Oncology - STAT News

Added to Collection on: 2024-05-02 17:36:09

Tags for this article:

Novartis
Radiopharmaceuticals
Prostate cancer
Lutetium (177Lu) vipivotide tetraxetan
Pharmaceutical industry
Radiation therapy

Click the tags to see associated articles and topics

View Article Details
Fusion Pharmaceuticals doses first subject in prostate cancer trial

Added to Collection on: 2024-05-10 23:17:30

Tags for this article:

Prostate cancer
Glutamate carboxypeptidase II
Molecular neuroscience
Neurotransmitters
Proteases
Radiopharmaceuticals
Lutetium (177Lu) vipivotide tetraxetan

Click the tags to see associated articles and topics

View Article Details
Study establishes proof of concept for TLX592 in prostate cancer - Urology Times

Added to Collection on: 2024-05-21 20:34:18

Tags for this article:

Medical isotopes
Lutetium (177Lu) vipivotide tetraxetan
Radiopharmaceuticals
Prostate cancer
Actinium
Telix Pharmaceuticals Limited
telix pharmaceuticals

Click the tags to see associated articles and topics

View Article Details
Radioligand Therapies Market to Show Immense Growth by 2034, Predicts DelveInsight

Added to Collection on: 2024-07-09 21:31:56

Tags for this article:

Biomolecules
Radioligand
Receptors
Radiation therapy
Advanced Accelerator Applications
Prostate cancer
Lutetium (177Lu) vipivotide tetraxetan
Novartis
Radiopharmaceutical
Amgen
Endocyte
Glutamate carboxypeptidase II
France
Japan
United Kingdom
Germany
Italy
United States
Spain

Click the tags to see associated articles and topics

View Article Details
Blue Earth Therapeutics partners with UCL for prostate cancer therapy trial

Added to Collection on: 2024-07-24 21:34:40

Tags for this article:

Prostate cancer
Lutetium (177Lu) vipivotide tetraxetan
Radiopharmaceuticals
Radioligand
Radiation therapy
Lutetium
PSMA scan
Advanced Accelerator Applications
United Kingdom

Click the tags to see associated articles and topics

View Article Details
Book a Demo